Santa Cruz Biotechnology offers a broad range of Lipid A monoclonal antibodies for various research applications. Lipid A monoclonal antibodies are essential tools for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Lipid A is a crucial component of lipopolysaccharides found in the outer membrane of Gram-negative bacteria, playing a significant role in immune response and bacterial virulence. Its recognition by the immune system is essential for the activation of innate immunity, making Lipid A a key target for understanding bacterial infections and developing therapeutic strategies. The study of Lipid A is vital for advancing our knowledge of host-pathogen interactions and the mechanisms of sepsis. Researchers worldwide rely on Lipid A monoclonal antibodies to investigate bacterial membrane structure and function. Understanding Lipid A's role in bacterial infections has led to significant breakthroughs in therapeutic development. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to microbiology and immunology research.